Ambroxol Hydrochloride + Salbutamol Sulphate + Dextromethorphan HydrobromideThird Party Manufacturing in India

This combination brings together three active agents that target different pathways of the respiratory tract. Ambroxol Hydrochloride acts as a mucolytic and secretolytic agent. It depolymerizes mucopolysaccharide fibers in respiratory secretions and stimulates pulmonary surfactant production, reducing mucus viscosity and adhesion to bronchial walls. Salbutamol Sulphate is a selective beta-2 adrenergic receptor agonist that acts directly on bronchial smooth muscle. By stimulating adenylate cyclase and increasing intracellular cyclic AMP, it relaxes bronchial smooth muscle and induces rapid bronchodilation, relieving airway constriction. Dextromethorphan Hydrobromide acts centrally on the cough center in the medulla oblongata to increase the cough threshold, suppressing non-productive, irritating coughs. Together, this combination liquefies tenacious secretions, dilates the airways to facilitate respiration, and regulates excessive coughing.

Ambroxol Hydrochloride + Salbutamol Sulphate + Dextromethorphan Hydrobromide third party manufacturing in India is a major segment of our liquid oral respiratory portfolio, supplying high-quality cough syrups for both domestic and international markets.

Therapeutic Uses

Ambroxol + Salbutamol + Dextromethorphan syrup is prescribed for the symptomatic management of:

• Bronchospasm with Productive Cough: Relieves chest tightness and wheezing while helping clear thick bronchial secretions.
• Acute Bronchitis: Eases breathing and helps thin and expel mucus during acute respiratory tract infections.
• Chronic Obstructive Pulmonary Disease (COPD): Provides relief from cough and airway obstruction in chronic bronchitic conditions.

Why Choose a Leading Ambroxol + Salbutamol + Dextromethorphan Manufacturer

This combination syrup is popular in the Indian domestic and export markets due to its multi-symptom relief approach. By combining a mucolytic, a bronchodilator, and an antitussive, it addresses mucus congestion, bronchospasm, and cough reflex simultaneously, improving patient compliance compared to multiple individual medications. Sourcing this syrup from a WHO-GMP certified facility in India ensures precise dosing, product stability, and high quality. Sourcing from WHO-GMP certified partner facilities guarantees high purity, reliable liquid fill operations, and complete documentation for domestic and export licensing.

This makes Ambroxol + Salbutamol + Dextromethorphan one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.